Reducing disparities across the European Union 

Despite significant advances in cancer therapy, there is still a long road ahead to improve disparities in cancer screening, diagnosis, treatment, quality of life, management of survivorship, and palliative care at the end of life. Among the challenges encountered within and across Europe, the most common disparities are observed in accessing information, spiraling costs of healthcare, accessing optimal treatment options with complete treatment modalities and optimal outcomes, ensuring the best Quality of Life for patients during and after the treatment process, integrating cancer research and innovative cancer care, and accessing networked, multidisciplinary cancer care teams.

In response to this concerning scenario, the Cancer Care Beacon project focuses on three iterative pillars:

  1. mapping of capacity and capabilities across cancer centers in the European Union;
  2. creating decision support tools that will assist our four stakeholders: patients in finding the best centers, providers in sharing resources and expertise, researchers in sharing data, and policymakers in aligning funding allocation with patients' priorities;
  3. getting training and accreditation to reflect the quality of their cancer care.

Throughout this project, we will deliver three main end products:

  • proposed roadmap to scale current capacity and capabilities in order to address existing cancer disparities,
  • a plethora of reports, including both static documents and interactive Web applications, aimed at supporting decision making by our four stakeholders,
  • a sustainability plan on how we intend to directly work with our partners to keep the project alive and active beyond the two-year duration of the funding by EU4Health.


The Cancer Care Beacon project focuses on three iterative pillars:




Improving collaboration among different types of stakeholders.


Coppini V, Ferraris G, Monzani D, Grasso R and Pravettoni G (2023). Disparities and barriers in the assessment of psychological distress, access to and use of psycho-oncological support in Europe: current perspectives.  Front. Psychol. 14:1252843. doi: 10.3389/fpsyg.2023.1252843

Horgan, D., Capoluongo, E., Dube, F., Trapani, D., Malapelle, U., Rovite, V., Omar, M., Alix-Panabières, C., Rutkowski, P., Bayle, A., Hackshaw, A., Hofman, P. & Subbiah, V. (2023). Clouds across the new dawn for clinical, diagnostic and biological data: accelerating the development, delivery and uptake of personalized medicine. Diagnosis. 


Ferraris, G., Monzani, D., Coppini, V., Conti, L., Pizzoli, S.F. M., Grasso, R., Pravettoni G. (2023). Barriers to and facilitators of online health information-seeking behaviours among cancer patients: A systematic review. Digital Health, 9. 

Ferraris G, Coppini V, Monzani D, Grasso R, Kirac I, Horgan D, Pietrobon R, Galvão V and Pravettoni G (2024). Addressing disparities in European cancer outcomes: a qualitative study protocol of the BEACON project. Frontiers Psychology 15:1252832. doi: 10.3389/fpsyg.2024.1252832





BEACON - Cancer Care Beacon - Reducing Disparities Across the European Union
See how our project contribute to the implementation of the European Beating Cancer Plan 

This project has received funding from the European Union’s EU4Health Programme (EU4H) under Grant Agreement Number: 101080005




Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.



  • BEACON High Level Conference - May 16th/17th 2024

    The BEACON consortium is organising a High Level Conference in Warsaw on May 16th/17th entitled ‘Mobilising Collaboration among Stakeholders to Optimise the Growing Potential of Data for Tackling Cancer’.  

    This event is part of the EU funded project entitled BEACON.  The purpose of the meeting is to get key input from stakeholders as well as policy makers to ensure that the implementation of the EU beating Cancer plan meets their needs.  

    A core objective of the stakeholder event  is: 

    • - to assess and address obstacles to the integration to improve the capacity and capability of tackling cancer through public-private partnerships
    • - to identify best practices and their added value 
    • - to develop a policy roadmap  to support funding so as to bring ‘Access and Diagnostics for All’ as well as improve the capacity of the Cancer center.


    You can find the preliminary agenda here.

    You can register for the event here.

  • 24th IPOS World Congress of Psycho-Oncology

    Beacon Cancer Care actively took part in the World Congress of Psycho-Oncology (IPOS), which was held in Milan from August 31st to September 3rd, 2023. Throughout this conference, we had the privilege of sharing the initial findings of the BEACON project. Our symposium was dedicated to discussing the obstacles and potential solutions in addressing cancer disparities across Europe. If you're interested, you can access the Abstract Booklet of the Conference by visiting this link

  • BEACON - Developing a Sustainability Model: Stakeholder Meeting & Expert Panel

    As part of the BEACON project, the European Alliance for Personalised Medicine as the leading organization for Work Package 1 prepared 12 separate videos during the High-level BEACON Stakeholder Seminar entitled “Cancer Care Beacon - Reducing Disparities Across the European Union (BEACON):  Developing an outline of "Sustainability Model” which took place in Zagreb on February 16th and 17th, 2023.

     Videos are availabe here!

  • BEACON – Plenary Meeting in Palermo

    Palermo, Italy - On the 29th and 30th of November, the BEACON Consortium gathered at the University of Palermo to discuss the challenges and solutions of the project and to share insights on the upgraded Beacon Cancer Care Wiki, a comprehensive hub for cancer centers across Europe.





Università degli Studi di Milano


Ministero della Salute Joint Commission International bollinirosa

© 2013 Istituto Europeo di Oncologia - via Ripamonti 435 Milano - P.I. 08691440153 - Codice intermediario fatturazione elettronica: A4707H7